Delivery Order SPE2DB20D9331-SPE2DB25FL1Y3
Award Date 9/10/25
Potential Completion Date 10/1/25
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order valued at $27,961.92 to DMS Pharmaceutical Group Inc. for the supply of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used for emergency reversal of anticoagulation. The award, effective August 25, 2025 with completion targeted for September 16, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a $7,296.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,539.52 by the Defense Logistics Agency on August 18, 2025, for the supply of Kcentra 500 unit vials. The contract carries an ultimate completion date of September 9, 2025, and is not designated under any set-aside program. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $27,961.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 19, 2025, for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor complex used for treating bleeding associated with warfarin or novel anticoagulant overdose. This delivery order, with an ultimate completion date of September 10, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $93,282.40 by the Defense Logistics Agency (DLA) on August 28, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical settings. The delivery order carries an ultimate completion date of September 19, 2025, and was issued without a set-aside...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,602.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the blood coagulant Kcentra, with a completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,477.76 by the Defense Logistics Agency (DLA) on August 21, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical treatment. This delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 25, 2025, by the Defense Logistics Agency (DLA) for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used to reverse anticoagulation. The firm fixed-price delivery order has a ceiling value of $19,845.12 with an ultimate completion date of August 15, 2025. This award was issued without a set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $18,641.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $13,655.68 order is for 1,000 unit vials of the drug Kcentra, with a performance period through August 7, 2024. The award is made under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a wide range of pharmaceutical products and...